Dr Prasum Mishra
CEO
 

Dr. Mishra (Ex-Genentech, Ex-NCI, Ex-NIH) is the founder and CEO of Agility Pharmaceuticals (Agility), based in San Francisco Bay Area, CA. Agility pharma is one of the leading artificial intelligence (AI)-driven pharmaceutical companies, as evident by key partnerships and recognition by scientific and tech community. He is also founding president and CEO of American Association for Precision Medicine (AAPM). He is best known for discovering the role for noncoding RNA in drug resistance and pharmacogenomics. Moreover, his passion for drug development and precision medicine has led to identification of new drug targets, biomarkers, companion diagnostics, and mechanisms of action/resistance of both new and established drugs, which has facilitated development of rational drug combinations in the clinic. His research work has been recognized globally by numerous awards and honors. In addition to his professional commitments, Dr. Mishra also gives back to his local biotech community by serving as an advisor to several companies in the San Francisco Bay Area to advance their R&D and funding strategy. The companies that he has advised have raised multimillion dollars. Notably, he serves as a mentor and advisor to startup accelerators such as IndieBio, Project Zygote and California Life Sciences Association, to help grow California’s life sciences innovation ecosystem. Moreover, discoveries lead by Dr. Mishra and his teams have contributed to the development of new and viable strategies of prevention, diagnosis and treatment of patients in the clinic.